#KidneyWk on X 10 hours ago

RT @asnpublications: Did you miss the ASN Presidential Address at #KidneyWk? Read the address in #ASNKidneyNews, featuring a discussion of…

View Post

#KidneyWk on X 22 hours ago

Did you miss the ASN Presidential Address at #KidneyWk? Read the address in #ASNKidneyNews, featuring a discussion of momentum and challenges in th...

View Post

#KidneyWk on X 23 hours ago

Finerenone use for 6 months was safe and associated with a significant 25% decrease in albuminuria for adults with type 1 #diabetes and #chronickid...

View Post

#KidneyWk on X 1 day ago

#AI use in nephrology requires constant updates and a “human-in-the-loop,” according to a panel discussion at #KidneyWk. Learn more about @ASNKidn...

View Post

#KidneyWk on X 1 day ago

RT @Nephronline: In an interim analysis of the ORIGIN 3 clinical trial, the novel IgA nephropathy drug atacicept nearly halved proteinuria…

View Post

#KidneyWk on X 1 day ago

WATCH Matthew Weir, MD, discussing results from the phase 2 Explore-CKD trial of lorundrostat presented at #KidneyWk. #nephrology #nephtwitter #kid...

View Post

#KidneyWk on X 1 day ago

In an interim analysis of the ORIGIN 3 clinical trial, the novel IgA nephropathy drug atacicept nearly halved proteinuria among adults with IgA nep...

View Post

#KidneyWk on X 2 days ago

RT @kidney_boy: Who and how to give an SGLT2i to a type 1 DM patient #KidneyWk https://t.co/VfsBBnuIWw

View Post

#KidneyWk on X 2 days ago

One week left! Don’t miss your chance to claim continuing education credits and MOC points. If you attended #KidneyWk, be sure to: ✅ Complete eval...

View Post

#KidneyWk on X 3 days ago

RT @NEJM: Original Article: Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis (PISCES trial) https://t.…

View Post